Portfolio (Quarterly)
Guide ↗
Defilade Capital Management, L.P.
· CIK 0002088557| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZBH | ZIMMER BIOMET HOLDINGS INC | Healthcare | 579,161.0 | $52.4M | 7.35% | NEW | — | $90.42 | -5.8% |
| 2 | PTCT | PTC THERAPEUTICS INC | Healthcare | 376,165.0 | $41.1M | 5.77% | NEW | — | $109.29 | -35.8% |
| 3 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 209,932.0 | $27.7M | 3.88% | NEW | — | $131.74 | +19.3% |
| 4 | LNTH | LANTHEUS HLDGS INC | Healthcare | 249,401.0 | $18.9M | 2.66% | NEW | — | $75.85 | +22.8% |
| 5 | ITGR | INTEGER HLDGS CORP | Healthcare | 213,027.0 | $18.7M | 2.63% | NEW | — | $88.00 | +2.2% |
| 6 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 761,905.0 | $14.6M | 2.05% | NEW | — | $19.17 | -29.4% |
| 7 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 842,928.0 | $10.7M | 1.50% | NEW | — | $12.67 | -37.4% |
| 8 | — | BIOHAVEN LTD | — | 315,944.0 | $2.7M | 0.38% | NEW | — | $8.46 | — |
| 9 | MREO | MEREO BIOPHARMA GROUP PLC | Healthcare | 7,558,756.0 | $2.5M | 0.35% | NEW | — | $0.33 | -27.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.2%
Financial Services
3.8%